Paper41379754
Evaluation of the Effect of Clobetasol Propionate on Circulating Cortisol and Growth Velocity in Children with Atopic Dermatitis: A Modelling and Simulation Study.
Duong JK and 6 others. Dermatology, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Evaluation of the Effect of Clobetasol Propionate on Circulating Cortisol and Growth Velocity in Children with Atopic Dermatitis: A Modelling and Simulation Study. Papers, record 41379754. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41379754
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evaluation of the Effect of Clobetasol Propionate on Circulating Cortisol and Growth Velocity in Children with Atopic Dermatitis: A Modelling and Simulation Study.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hydrocortisone | Major topic |
| Dermatitis, Atopic | Major topic |
| Clobetasol | Major topic |
| Glucocorticoids | Major topic |
| Humans | |
| Child | |
| Child, Preschool | |
| Infant | |
| Adolescent | |
| Female | |
| Male | |
| Skin Absorption | |
| Computer Simulation | |
| Models, Biological | |
| Administration, Cutaneous |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 41855357 | Erratum. | https://conductscience.org/library/papers/41855357 |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37589831 | Understanding the Clinical Implications of Individual Patient Characteristics and Treatment Choice on the Risk of Exacerbation in Asthma Patients with Moderate-Severe Symptoms. | Adv Ther | 2023 | https://conductscience.org/library/papers/37589831 | PubMed |
| 2 | 20972726 | Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature. | Endocrine | 2010 | https://conductscience.org/library/papers/20972726 | PubMed |
| 3 | 27206013 | Atopic dermatitis and filaggrin. | Curr Opin Immunol | 2016 | https://conductscience.org/library/papers/27206013 | PubMed |
| 4 | 18539358 | Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. | J Am Acad Dermatol | 2008 | https://conductscience.org/library/papers/18539358 | PubMed |
| 5 | 25925336 | Atopic dermatitis: global epidemiology and risk factors. | Ann Nutr Metab | 2015 | https://conductscience.org/library/papers/25925336 | PubMed |
| 6 | 14623701 | The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease. | Arch Dermatol | 2003 | https://conductscience.org/library/papers/14623701 | PubMed |
| 7 | 37152231 | Assessing anatomical distribution of atopic dermatitis identifies a cluster of patients with late onset and low risk of asthma and allergy: An observational study. | Health Sci Rep | 2023 | https://conductscience.org/library/papers/37152231 | PubMed |
| 8 | 29315504 | Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective. | Clin Pharmacol Ther | 2018 | https://conductscience.org/library/papers/29315504 | PubMed |
| 9 | 16935684 | Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. | Lancet | 2006 | https://conductscience.org/library/papers/16935684 | PubMed |
| 10 | 30439301 | Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section IV: Treatment Options for the Management of Atopic Dermatitis. | J Cutan Med Surg | 2018 | https://conductscience.org/library/papers/30439301 | PubMed |
| 11 | 16971317 | How much of a topical agent should be prescribed for children of different sizes? | J Dermatolog Treat | 2006 | https://conductscience.org/library/papers/16971317 | PubMed |
| 12 | 38775304 | Population pharmacokinetics and dose rationale for aciclovir in term and pre-term neonates with herpes. | Pharmacol Res Perspect | 2024 | https://conductscience.org/library/papers/38775304 | PubMed |
| 13 | 6614406 | Development of asthma, allergic rhinitis and atopic dermatitis by the age of five years. A prospective study of 543 newborns. | Allergy | 1983 | https://conductscience.org/library/papers/6614406 | PubMed |
| 14 | 16384751 | Adverse effects of topical glucocorticosteroids. | J Am Acad Dermatol | 2006 | https://conductscience.org/library/papers/16384751 | PubMed |
| 15 | 34840742 | Topical corticosteroid-induced iatrogenic cushing syndrome in an infant; a case report with literature review. | Ann Med Surg (Lond) | 2021 | https://conductscience.org/library/papers/34840742 | PubMed |
| 16 | 9764151 | Severity distribution of atopic dermatitis in the community and its relationship to secondary referral. | Br J Dermatol | 1998 | https://conductscience.org/library/papers/9764151 | PubMed |
| 17 | 1125562 | Cushing's syndrome and pituitary-adrenal suppression due to clobetasol propionate. | Br Med J | 1975 | https://conductscience.org/library/papers/1125562 | PubMed |
| 18 | 23586744 | Early recognition of growth abnormalities permitting early intervention. | Acta Paediatr | 2013 | https://conductscience.org/library/papers/23586744 | PubMed |
| 19 | 29184808 | Recovery of steroid induced adrenal insufficiency. | Transl Pediatr | 2017 | https://conductscience.org/library/papers/29184808 | PubMed |
| 20 | 38532238 | Pharmacological Basis of Differences in Dose Response, Dose Equivalence, and Duration of Action of Inhaled Corticosteroids. | Adv Ther | 2024 | https://conductscience.org/library/papers/38532238 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41379754
GET https://conductscience.org/api/papers/v1/41379754/references?page=2